As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree.
An ambitious and innovative new initiative expands opportunities for faculty, alumni and students across the university to engage with 20 partner universities in 11 locations, while also welcoming international students here.
Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.
Pound for pound, the brain consumes vastly more energy than other organs. Now, researchers at Weill Cornell Medicine have found that the process of packaging neurotransmitters may be responsible for this energy drain.
Soumitra Dutta, professor of management and former founding dean of the Cornell SC Johnson College of Business, will leave Cornell this summer to become dean of the Saïd Business School of the University of Oxford.
The Office of Academic Integration has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and antibiotic tolerance.
From agriculture to AI to healthcare, Cornell Tech alumni are driving social change. Read about three recent graduates who showcase a few of the creative ways alumni are using their Cornell Tech degree.
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from Cornell researchers.
Obesity may spur DNA damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to breast cancer development in this already high-risk group, according to new multi-institutional translational research led by Weill Cornell Medicine scientists.
Anti-Mullerian hormone, traditionally thought of as a passive byproduct of polycystic ovary syndrome, may actually play an active role in the disorder, according to new research.